United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 11, 2026 · Filed May 12, 2026

On May 11, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$573.10 for US$5.44M under a trading plan, leaving 40,513 shares. Filed May 12, 2026 (Form 4).

Sold
9,500 shares
Price
US$573.10 average (US$569.50 to US$580.44)
Value
US$5.44M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 11, 2026Common StockSale1,165US$569.5048,848Direct
May 11, 2026Common StockSale2,019US$570.2146,829Direct
May 11, 2026Common StockSale1,356US$571.4345,473Direct
May 11, 2026Common StockSale1,292US$572.3944,181Direct
May 11, 2026Common StockSale397US$573.1843,784Direct
May 11, 2026Common StockSale578US$574.3843,206Direct
May 11, 2026Common StockSale658US$575.3342,548Direct
May 11, 2026Common StockSale210US$576.9342,338Direct
May 11, 2026Common StockSale964US$577.8041,374Direct
May 11, 2026Common StockSale227US$578.7341,147Direct
May 11, 2026Common StockSale514US$579.8540,633Direct
May 11, 2026Common StockSale120US$580.4440,513Direct

Source

View original at SEC

Related